Cryo-Cell International, Inc.
CCEL
$3.40
$0.041.19%
AMEX
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 7.78M | 7.68M | 7.84M | 7.83M | 7.93M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.78M | 7.68M | 7.84M | 7.83M | 7.93M |
| Cost of Revenue | 1.68M | 1.66M | 6.09M | 1.80M | 1.86M |
| Gross Profit | 6.10M | 6.03M | 1.75M | 6.02M | 6.07M |
| SG&A Expenses | 4.62M | 5.01M | 5.45M | 3.88M | 4.26M |
| Depreciation & Amortization | 184.30K | 183.90K | 183.80K | 185.70K | 190.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.58M | 6.92M | 11.81M | 5.92M | 6.44M |
| Operating Income | 1.20M | 765.10K | -3.97M | 1.90M | 1.49M |
| Income Before Tax | 827.80K | 70.30K | -4.63M | 1.19M | 575.10K |
| Income Tax Expenses | 273.20K | 23.20K | -814.50K | 436.60K | 219.30K |
| Earnings from Continuing Operations | 554.60K | 47.10K | -3.82M | 749.40K | 355.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 554.60K | 47.10K | -3.82M | 749.40K | 355.80K |
| EBIT | 1.20M | 765.10K | -3.97M | 1.90M | 1.49M |
| EBITDA | 1.44M | 1.01M | -3.72M | 2.14M | 1.74M |
| EPS Basic | 0.07 | 0.01 | -0.47 | 0.09 | 0.04 |
| Normalized Basic EPS | 0.06 | 0.02 | -0.34 | 0.11 | 0.07 |
| EPS Diluted | 0.07 | 0.01 | -0.47 | 0.09 | 0.04 |
| Normalized Diluted EPS | 0.06 | 0.02 | -0.34 | 0.11 | 0.07 |
| Average Basic Shares Outstanding | 8.06M | 8.06M | 8.06M | 8.06M | 8.08M |
| Average Diluted Shares Outstanding | 8.06M | 8.06M | 8.06M | 8.07M | 8.13M |
| Dividend Per Share | -- | -- | 0.00 | 0.00 | 0.15 |
| Payout Ratio | -- | -- | 0.00% | 0.00% | 340.29% |